Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy.
- 7 July 1997
- journal article
- clinical trial
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 5 (4) , 289-298
- https://doi.org/10.1007/pl00009894
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: